Skip to main content
Erschienen in: Rheumatology International 1/2016

01.01.2016 | Short Communication - Observational Research

Risk of Sjögren’s syndrome in Taiwanese female adults with irregular menstrual cycles: a population-based case–control study

verfasst von: Ming-Chi Lu, Min-Chih Hsieh, Malcolm Koo, Ning-Sheng Lai

Erschienen in: Rheumatology International | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Primary Sjögren’s syndrome (pSS) is a progressive systemic autoimmune disorder with a strong female predominance. Hormonal influences are thought to play a role in the development of pSS. However, no studies have specifically evaluated the association between irregular menstrual cycles and pSS. Therefore, using a health claims database, this study investigated the risk of pSS in women with irregular menstrual cycles. We conducted a case–control study using the Taiwan’s National Health Insurance Research Database. A total of 360 patients diagnosed with pSS (International Classification of Diseases, ninth revision, clinical modification, ICD-9-CM code 710.2) between 2001 and 2012 were identified. Controls were frequency-matched at a rate of 5:1 to the cases by five-year age interval and index year. Both cases and controls were retrospectively traced back until 2001 for the diagnosis of irregular menstrual cycles (ICD-9-CM code 626.4). The risk of pSS was assessed using multivariate logistic regression analyses. Irregular menstrual cycles were significantly associated with pSS [adjusted odds ratio, (AOR) = 1.38, p = 0.027], after adjusted for insured amount, urbanization level, and thyroid disorder. In addition, when the data were stratified by three age categories, only the patients in the age category of 45–55 years showed significant association between irregular menstrual cycles and pSS (AOR = 1.74, p = 0.005). In this nationwide, population-based case–control study, we found a significant increased risk of pSS in female patients with irregular menstrual cycles, particularly those in their mid-forties to mid-fifties.
Literatur
1.
Zurück zum Zitat Rosenfield RL (2013) Clinical review: adolescent anovulation: maturational mechanisms and implications. J Clin Endocrinol Metab 98(9):3572–3583PubMedPubMedCentralCrossRef Rosenfield RL (2013) Clinical review: adolescent anovulation: maturational mechanisms and implications. J Clin Endocrinol Metab 98(9):3572–3583PubMedPubMedCentralCrossRef
2.
Zurück zum Zitat Hull MG (1987) Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. Gynecol Endocrinol 1(3):235–245PubMedCrossRef Hull MG (1987) Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. Gynecol Endocrinol 1(3):235–245PubMedCrossRef
3.
Zurück zum Zitat Franks S, Adams J, Mason H, Polson D (1985) Ovulatory disorders in women with polycystic ovary syndrome. Clin Obstet Gynaecol 12(3):605–632PubMed Franks S, Adams J, Mason H, Polson D (1985) Ovulatory disorders in women with polycystic ovary syndrome. Clin Obstet Gynaecol 12(3):605–632PubMed
4.
Zurück zum Zitat Solomon CG, Hu FB, Dunaif A, Rich-Edwards J, Willett WC, Hunter DJ, Colditz GA, Speizer FE, Manson JE (2001) Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus. JAMA 286(19):2421–2426PubMedCrossRef Solomon CG, Hu FB, Dunaif A, Rich-Edwards J, Willett WC, Hunter DJ, Colditz GA, Speizer FE, Manson JE (2001) Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus. JAMA 286(19):2421–2426PubMedCrossRef
5.
Zurück zum Zitat Solomon CG, Hu FB, Dunaif A, Rich-Edwards JE, Stampfer MJ, Willett WC, Speizer FE, Manson JE (2002) Menstrual cycle irregularity and risk for future cardiovascular disease. J Clin Endocrinol Metab 87(5):2013–2017PubMedCrossRef Solomon CG, Hu FB, Dunaif A, Rich-Edwards JE, Stampfer MJ, Willett WC, Speizer FE, Manson JE (2002) Menstrual cycle irregularity and risk for future cardiovascular disease. J Clin Endocrinol Metab 87(5):2013–2017PubMedCrossRef
6.
Zurück zum Zitat Wang ET, Cirillo PM, Vittinghoff E, Bibbins-Domingo K, Cohn BA, Cedars MI (2011) Menstrual irregularity and cardiovascular mortality. J Clin Endocrinol Metab 96(1):E114–E118PubMedPubMedCentralCrossRef Wang ET, Cirillo PM, Vittinghoff E, Bibbins-Domingo K, Cohn BA, Cedars MI (2011) Menstrual irregularity and cardiovascular mortality. J Clin Endocrinol Metab 96(1):E114–E118PubMedPubMedCentralCrossRef
7.
Zurück zum Zitat Minami Y, Sasaki T, Komatsu S, Nishikori M, Fukao A, Yoshinaga K, Hisamichi S (1993) Female systemic lupus erythematosus in Miyagi Prefecture, Japan: a case-control study of dietary and reproductive factors. Tohoku J Exp Med 169(3):245–252PubMedCrossRef Minami Y, Sasaki T, Komatsu S, Nishikori M, Fukao A, Yoshinaga K, Hisamichi S (1993) Female systemic lupus erythematosus in Miyagi Prefecture, Japan: a case-control study of dietary and reproductive factors. Tohoku J Exp Med 169(3):245–252PubMedCrossRef
8.
Zurück zum Zitat Costenbader KH, Feskanich D, Stampfer MJ, Karlson EW (2007) Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. Arthritis Rheum 56(4):1251–1262PubMedCrossRef Costenbader KH, Feskanich D, Stampfer MJ, Karlson EW (2007) Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. Arthritis Rheum 56(4):1251–1262PubMedCrossRef
9.
Zurück zum Zitat Reksten TR, Jonsson MV (2014) Sjögren’s syndrome: an update on epidemiology and current insights on pathophysiology. Oral Maxillofac Surg Clin North Am 26:1–12PubMedCrossRef Reksten TR, Jonsson MV (2014) Sjögren’s syndrome: an update on epidemiology and current insights on pathophysiology. Oral Maxillofac Surg Clin North Am 26:1–12PubMedCrossRef
10.
Zurück zum Zitat Weng MY, Huang YT, Liu MF, Lu TH (2011) Incidence and mortality of treated primary Sjogren’s syndrome in Taiwan: a population-based study. J Rheumatol 38:706–708PubMedCrossRef Weng MY, Huang YT, Liu MF, Lu TH (2011) Incidence and mortality of treated primary Sjogren’s syndrome in Taiwan: a population-based study. J Rheumatol 38:706–708PubMedCrossRef
11.
Zurück zum Zitat Skopouli FN, Papanikolaou S, Malamou-Mitsi V, Papanikolaou N, Moutsopoulos HM (1994) Obstetric and gynaecological profile in patients with primary Sjögren’s syndrome. Ann Rheum Dis 53:569–573PubMedPubMedCentralCrossRef Skopouli FN, Papanikolaou S, Malamou-Mitsi V, Papanikolaou N, Moutsopoulos HM (1994) Obstetric and gynaecological profile in patients with primary Sjögren’s syndrome. Ann Rheum Dis 53:569–573PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Marchesoni D, Mozzanega B, De Sandre P, Romagnolo C, Gambari P, Maggino T (1995) Gynaecological aspects of primary Sjogren’s syndrome. Eur J Obstet Gynecol Reprod Biol 63(1):49–53PubMedCrossRef Marchesoni D, Mozzanega B, De Sandre P, Romagnolo C, Gambari P, Maggino T (1995) Gynaecological aspects of primary Sjogren’s syndrome. Eur J Obstet Gynecol Reprod Biol 63(1):49–53PubMedCrossRef
13.
Zurück zum Zitat Mulherin DM, Sheeran TP, Kumararatne DS, Speculand B, Luesley D, Situnayake RD (1997) Sjögren’s syndrome in women presenting with chronic dyspareunia. Br J Obstet Gynaecol 104(9):1019–1023PubMedCrossRef Mulherin DM, Sheeran TP, Kumararatne DS, Speculand B, Luesley D, Situnayake RD (1997) Sjögren’s syndrome in women presenting with chronic dyspareunia. Br J Obstet Gynaecol 104(9):1019–1023PubMedCrossRef
14.
Zurück zum Zitat Haga HJ, Gjesdal CG, Irgens LM, Ostensen M (2005) Reproduction and gynaecological manifestations in women with primary Sjögren’s syndrome: a case-control study. Scand J Rheumatol 34(1):45–48PubMedCrossRef Haga HJ, Gjesdal CG, Irgens LM, Ostensen M (2005) Reproduction and gynaecological manifestations in women with primary Sjögren’s syndrome: a case-control study. Scand J Rheumatol 34(1):45–48PubMedCrossRef
17.
Zurück zum Zitat Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH, European Study Group on Classification Criteria for Sjögren’s Syndrome (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American–European Consensus Group. Ann Rheum Dis 61(6):554–558PubMedPubMedCentralCrossRef Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH, European Study Group on Classification Criteria for Sjögren’s Syndrome (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American–European Consensus Group. Ann Rheum Dis 61(6):554–558PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Lu MC, Yin WY, Tsai TY, Koo M, Lai NS (2013) Increased risk of primary Sjögren’s syndrome in female patients with thyroid disorders: a longitudinal population-based study in Taiwan. PLoS ONE 8(10):e77210PubMedPubMedCentralCrossRef Lu MC, Yin WY, Tsai TY, Koo M, Lai NS (2013) Increased risk of primary Sjögren’s syndrome in female patients with thyroid disorders: a longitudinal population-based study in Taiwan. PLoS ONE 8(10):e77210PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Liu CY, Hung YT, Chuang YL, Chen YJ, Weng WS, Liu JS, Liang KY (2006) Incorporating development stratification of Taiwan townships into sampling design of large scale health interview survey. J Health Manage 4:1–22 (in Chinese) Liu CY, Hung YT, Chuang YL, Chen YJ, Weng WS, Liu JS, Liang KY (2006) Incorporating development stratification of Taiwan townships into sampling design of large scale health interview survey. J Health Manage 4:1–22 (in Chinese)
20.
Zurück zum Zitat Pasoto SG, Mendonça BB, Bonfá E (2002) Menstrual disturbances in patients with systemic lupus erythematosus without alkylating therapy: clinical, hormonal and therapeutic associations. Lupus 11(3):175–180PubMedCrossRef Pasoto SG, Mendonça BB, Bonfá E (2002) Menstrual disturbances in patients with systemic lupus erythematosus without alkylating therapy: clinical, hormonal and therapeutic associations. Lupus 11(3):175–180PubMedCrossRef
21.
Zurück zum Zitat Shabanova SS, Ananieva LP, Alekberova ZS, Guzov II (2008) Ovarian function and disease activity in patients with systemic lupus erythematosus. Clin Exp Rheumatol 26(3):436–441PubMed Shabanova SS, Ananieva LP, Alekberova ZS, Guzov II (2008) Ovarian function and disease activity in patients with systemic lupus erythematosus. Clin Exp Rheumatol 26(3):436–441PubMed
22.
Zurück zum Zitat Costenbader KH, Feskanich D, Stampfer MJ, Karlson EW (2007) Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. Arthritis Rheum 56(4):1251–1262PubMedCrossRef Costenbader KH, Feskanich D, Stampfer MJ, Karlson EW (2007) Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. Arthritis Rheum 56(4):1251–1262PubMedCrossRef
23.
Zurück zum Zitat Shen SY, Huang SY, Hsieh CH, Hsu MI, Cheng CY, Hsu CS (2014) Clinical and biochemical characteristics of women with menstrual disturbance. Taiwan J Obstet Gynecol 53(2):178–182PubMedCrossRef Shen SY, Huang SY, Hsieh CH, Hsu MI, Cheng CY, Hsu CS (2014) Clinical and biochemical characteristics of women with menstrual disturbance. Taiwan J Obstet Gynecol 53(2):178–182PubMedCrossRef
24.
Zurück zum Zitat Oertelt-Prigione S (2012) The influence of sex and gender on the immune response. Autoimmun Rev 11(6–7):A479–A485PubMedCrossRef Oertelt-Prigione S (2012) The influence of sex and gender on the immune response. Autoimmun Rev 11(6–7):A479–A485PubMedCrossRef
25.
Zurück zum Zitat Ngo ST, Steyn FJ, McCombe PA (2014) Gender differences in autoimmune disease. Front Neuroendocrinol 35(3):347–369PubMedCrossRef Ngo ST, Steyn FJ, McCombe PA (2014) Gender differences in autoimmune disease. Front Neuroendocrinol 35(3):347–369PubMedCrossRef
26.
Zurück zum Zitat Porola P, Laine M, Virkki L, Poduval P, Konttinen YT (2007) The influence of sex steroids on Sjögren’s syndrome. Ann N Y Acad Sci 1108:426–432PubMedCrossRef Porola P, Laine M, Virkki L, Poduval P, Konttinen YT (2007) The influence of sex steroids on Sjögren’s syndrome. Ann N Y Acad Sci 1108:426–432PubMedCrossRef
27.
Zurück zum Zitat Konttinen YT, Fuellen G, Bing Y, Porola P, Stegaev V, Trokovic N, Falk SS, Liu Y, Szodoray P, Takakubo Y (2012) Sex steroids in Sjögren’s syndrome. J Autoimmun 39(1–2):49–56PubMedCrossRef Konttinen YT, Fuellen G, Bing Y, Porola P, Stegaev V, Trokovic N, Falk SS, Liu Y, Szodoray P, Takakubo Y (2012) Sex steroids in Sjögren’s syndrome. J Autoimmun 39(1–2):49–56PubMedCrossRef
Metadaten
Titel
Risk of Sjögren’s syndrome in Taiwanese female adults with irregular menstrual cycles: a population-based case–control study
verfasst von
Ming-Chi Lu
Min-Chih Hsieh
Malcolm Koo
Ning-Sheng Lai
Publikationsdatum
01.01.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 1/2016
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-015-3324-z

Weitere Artikel der Ausgabe 1/2016

Rheumatology International 1/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.